MedTrace Logo

Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia

NCT01385150 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2017-05-19

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors identify and lean more about biomarkers related to cancer.

PURPOSE: This research study is studying biomarkers in blood samples from patients with acute myeloid leukemia.

Conditions

Interventions

GENETIC

mutation analysis

GENETIC

protein analysis

OTHER

laboratory biomarker analysis

OTHER

liquid chromatography

OTHER

mass spectrometry

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Eastern Cooperative Oncology Group

    lead NETWORK

Principal Investigators

  • Courtney DiNardo, MD · Abramson Cancer Center at Penn Medicine

Eligibility

Min Age
17 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-03
Primary Completion
2012-02-03
Completion
2012-02-03

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01385150 on ClinicalTrials.gov